{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T02:02:33Z","timestamp":1790128953679,"version":"4.0.1"},"reference-count":28,"publisher":"American Diabetes Association","issue":"8","content-domain":{"domain":["diabetesjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2013,8,1]]},"abstract":"<jats:sec>\n                  <jats:title>OBJECTIVE<\/jats:title>\n                  <jats:p>Lipodystrophies are categorized by the extent of fat loss (generalized vs. partial) and by inheritance (congenital vs. acquired). We examined whether a group of patients with partial lipodystrophy of the limbs (PLL), type 2 diabetes mellitus (T2DM), and an absence of a family history of lipodystrophy constitute a new clinical subtype.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESEARCH DESIGN AND METHODS<\/jats:title>\n                  <jats:p>Ten women with T2DM and PLL were identified in academic diabetes clinics and were matched by age, sex, BMI, ethnicity, and diabetes status with 10 women with control T2DM without lipodystrophy. All patients were characterized by clinical evaluation and hyperinsulinemic clamp.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>RESULTS<\/jats:title>\n                  <jats:p>Patients with T2DM and PLL exhibited symmetrical loss of subcutaneous fat in forearms, or forearms plus calves, and acanthosis nigricans. Maximally stimulated glucose disposal rates were markedly reduced by 56% in the T2DM with PLL group compared with the control T2DM patients, whether normalized by body weight or surface area. Most PLL patients exhibited little or no insulin-mediated glucose uptake after subtraction of non-insulin\u2013mediated glucose uptake. The T2DM with PLL group also had greater elevations in hepatic transaminases and triglycerides and earlier onset of diabetes compared with control T2DM.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>CONCLUSIONS<\/jats:title>\n                  <jats:p>T2DM with PLL represents a previously unrecognized phenotype of lipodystrophy and of T2DM. These T2DM patients exhibit symmetrical lipodystrophy of the distal limbs, acanthosis nigricans, marked insulin resistance with little insulin-mediated glucose uptake, hypertriglyceridemia, and hepatic transaminase elevations, which are greater in severity than observed in patients with common T2DM.<\/jats:p>\n               <\/jats:sec>","DOI":"10.2337\/dc12-1529","type":"journal-article","created":{"date-parts":[[2013,2,20]],"date-time":"2013-02-20T02:58:42Z","timestamp":1361329122000},"page":"2247-2253","update-policy":"https:\/\/doi.org\/10.2337\/ada-journal-policies","source":"Crossref","is-referenced-by-count":23,"title":["Type 2 Diabetes With Partial Lipodystrophy of the Limbs"],"prefix":"10.2337","volume":"36","author":[{"given":"Leah R.","family":"Strickland","sequence":"first","affiliation":[{"name":"Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"University of Alabama School of Medicine, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fangjian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Lok","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Timothy","family":"Garvey","sequence":"additional","affiliation":[{"name":"Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, Alabama"},{"name":"Birmingham Veterans Affairs Medical Center, Birmingham, Alabama"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1167","published-online":{"date-parts":[[2013,7,11]]},"reference":[{"key":"2022031222202864200_B1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0002-9343(99)00414-3","article-title":"Lipodystrophies","volume":"108","author":"Garg","year":"2000","journal-title":"Am J Med"},{"key":"2022031222202864200_B2","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Engl J Med"},{"key":"2022031222202864200_B3","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.bbalip.2008.12.014","article-title":"Lipodystrophies: disorders of adipose tissue biology","volume":"1791","author":"Garg","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"2022031222202864200_B4","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031222202864200_B5"},{"key":"2022031222202864200_B6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1368-504X.2004.00389.x","article-title":"Dysfunctional fat cells, lipotoxicity and type 2 diabetes","volume":"Oct","author":"DeFronzo","year":"2004","journal-title":"Int J Clin Pract Suppl"},{"key":"2022031222202864200_B7","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1097\/MED.0b013e3283444b09","article-title":"Obesity, insulin resistance and free fatty acids","volume":"18","author":"Boden","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"2022031222202864200_B8","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2022031222202864200_B9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1007\/s001250051250","article-title":"Relation of triglyceride stores in skeletal muscle cells to central obesity and insulin sensitivity in European and South Asian men","volume":"42","author":"Forouhi","year":"1999","journal-title":"Diabetologia"},{"key":"2022031222202864200_B10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/diabetes.51.1.7","article-title":"Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes","volume":"51","author":"McGarry","year":"2002","journal-title":"Diabetes"},{"key":"2022031222202864200_B11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1159\/000282087","article-title":"Liver fat in the pathogenesis of insulin resistance and type 2 diabetes","volume":"28","author":"Yki-J\u00e4rvinen","year":"2010","journal-title":"Dig Dis"},{"key":"2022031222202864200_B12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1748-1716.2005.01502.x","article-title":"The role of adipokines as regulators of skeletal muscle fatty acid metabolism and insulin sensitivity","volume":"186","author":"Dyck","year":"2006","journal-title":"Acta Physiol (Oxf)"},{"key":"2022031222202864200_B13","doi-asserted-by":"crossref","first-page":"8456","DOI":"10.1074\/jbc.275.12.8456","article-title":"Mechanism of insulin resistance in A-ZIP\/F-1 fatless mice","volume":"275","author":"Kim","year":"2000","journal-title":"J Biol Chem"},{"key":"2022031222202864200_B14","doi-asserted-by":"crossref","first-page":"37676","DOI":"10.1074\/jbc.M111.250449","article-title":"Human 1-acylglycerol-3-phosphate O-acyltransferase isoforms 1 and 2: biochemical characterization and inability to rescue hepatic steatosis in Agpat2(-\/-) gene lipodystrophic mice","volume":"286","author":"Agarwal","year":"2011","journal-title":"J Biol Chem"},{"key":"2022031222202864200_B15","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00125-002-0873-y","article-title":"Adipose tissue as a buffer for daily lipid flux","volume":"45","author":"Frayn","year":"2002","journal-title":"Diabetologia"},{"key":"2022031222202864200_B16","doi-asserted-by":"crossref","first-page":"E1300","DOI":"10.1152\/ajpendo.90885.2008","article-title":"Muscle inflammatory response and insulin resistance: synergistic interaction between macrophages and fatty acids leads to impaired insulin action","volume":"296","author":"Varma","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2022031222202864200_B17","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1042\/BJ20111708","article-title":"Role and function of macrophages in the metabolic syndrome","volume":"442","author":"Bhargava","year":"2012","journal-title":"Biochem J"},{"key":"2022031222202864200_B18","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1073\/pnas.0905310107","article-title":"Inflammation and adipose tissue macrophages in lipodystrophic mice","volume":"107","author":"Herrero","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022031222202864200_B19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2337\/diab.34.3.222","article-title":"The effect of insulin treatment on insulin secretion and insulin action in type II diabetes mellitus","volume":"34","author":"Garvey","year":"1985","journal-title":"Diabetes"},{"key":"2022031222202864200_B20","first-page":"E632","article-title":"Estimation and kinetic analysis of insulin-independent glucose uptake in human subjects","volume":"244","author":"Gottesman","year":"1983","journal-title":"Am J Physiol"},{"key":"2022031222202864200_B21","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.metabol.2010.01.006","article-title":"Assessment of non-insulin-mediated glucose uptake: association with body fat and glycemic status","volume":"59","author":"Jumpertz","year":"2010","journal-title":"Metabolism"},{"key":"2022031222202864200_B22","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.2337\/diacare.26.6.1819","article-title":"K\u00f6bberling type of familial partial lipodystrophy: an underrecognized syndrome","volume":"26","author":"Herbst","year":"2003","journal-title":"Diabetes Care"},{"key":"2022031222202864200_B23","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/jc.2007-0654","article-title":"New metabolic phenotypes in laminopathies: LMNA mutations in patients with severe metabolic syndrome","volume":"92","author":"Decaudain","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"2022031222202864200_B24","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-011-2142-4","article-title":"Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPAR\u03b3 mutation (Y151C)","volume":"54","author":"Visser","year":"2011","journal-title":"Diabetologia"},{"key":"2022031222202864200_B25","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/MOL.0b013e32832d4a33","article-title":"Inherited lipodystrophies and hypertriglyceridemia","volume":"20","author":"Simha","year":"2009","journal-title":"Curr Opin Lipidol"},{"key":"2022031222202864200_B26"},{"key":"2022031222202864200_B27","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s00125-009-1502-9","article-title":"Efficacy of leptin therapy in the different forms of human lipodystrophy","volume":"53","author":"Chong","year":"2010","journal-title":"Diabetologia"},{"key":"2022031222202864200_B28","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1210\/jc.2011-2229","article-title":"Comparison of efficacy and safety of leptin replacement therapy in moderately and severely hypoleptinemic patients with familial partial lipodystrophy of the Dunnigan variety","volume":"97","author":"Simha","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Diabetes Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/8\/2247\/618739\/2247.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/diabetesjournals.org\/care\/article-pdf\/36\/8\/2247\/618739\/2247.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,13]],"date-time":"2022-03-13T00:35:07Z","timestamp":1647131707000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetesjournals.org\/care\/article\/36\/8\/2247\/33198\/Type-2-Diabetes-With-Partial-Lipodystrophy-of-the"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,11]]},"references-count":28,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,7,11]]},"published-print":{"date-parts":[[2013,8,1]]}},"URL":"https:\/\/doi.org\/10.2337\/dc12-1529","relation":{},"ISSN":["0149-5992","1935-5548"],"issn-type":[{"value":"0149-5992","type":"print"},{"value":"1935-5548","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,11]]}}}